Patent ID: 11945824
Assignee: ENANTA PHARMACEUTICALS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 6:
7. The compound of claim 1, represented by one of Formulae (XIIIa)˜(XIIId), or a pharmaceutically acceptable salt thereof:, , wherein R11 is independently optionally substituted —C1-C6 alkyl, optionally substituted C1-C6 alkoxyl, optionally substituted —C3-C6 cycloalkyl, halo, —CN, or —NRaRb; Ra and Rb are independently selected from hydrogen, optionally substituted —C1-C6 alkyl, optionally substituted —C3-C6 cycloalkyl, alternatively, Ra and Rb are taken together with nitrogen atom to which they attached to form an optionally substituted heterocyclic ring; each m is 0, 1, 2, 3, 4 or 5, and Y, G, and R4, are as defined in claim 1.